NYSEAMERICAN:VTAK Catheter Precision (VTAK) Stock Price, News & Analysis $2.52 -0.06 (-2.33%) As of 10:02 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock About Catheter Precision Stock (NYSEAMERICAN:VTAK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Catheter Precision alerts:Sign Up Key Stats Today's Range$2.49▼$2.5650-Day Range$2.45▼$6.2052-Week Range$2.39▼$42.75Volume4,509 shsAverage Volume679,928 shsMarket Capitalization$3.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina. Read More Catheter Precision Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreVTAK MarketRank™: Catheter Precision scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Catheter Precision. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Catheter Precision are expected to grow in the coming year, from ($8.90) to ($6.30) per share.Price to Book Value per Share RatioCatheter Precision has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Catheter Precision's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.19% of the float of Catheter Precision has been sold short.Short Interest Ratio / Days to CoverCatheter Precision has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Catheter Precision has recently increased by 1.87%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCatheter Precision does not currently pay a dividend.Dividend GrowthCatheter Precision does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.19% of the float of Catheter Precision has been sold short.Short Interest Ratio / Days to CoverCatheter Precision has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Catheter Precision has recently increased by 1.87%, indicating that investor sentiment is decreasing. News and Social Media3.0 / 5News Sentiment0.33 News SentimentCatheter Precision has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Catheter Precision this week, compared to 1 article on an average week.Search Interest1 people have searched for VTAK on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Catheter Precision to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Catheter Precision insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.95% of the stock of Catheter Precision is held by insiders.Percentage Held by InstitutionsOnly 20.34% of the stock of Catheter Precision is held by institutions.Read more about Catheter Precision's insider trading history. Receive VTAK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Catheter Precision and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VTAK Stock News HeadlinesCatheter Precision Announces First Procedures in France as LockeT Expansion ContinuesAugust 28 at 8:00 AM | globenewswire.comCatheter receives notification of new patent issuance for VIVO product lineAugust 25, 2025 | msn.comEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.August 29 at 2:00 AM | Timothy Sykes (Ad)Catheter Precision Receives Notification of New Patent Issuance for VIVO Product LineAugust 25, 2025 | finance.yahoo.comCatheter Precision begins enrollment for LockeT Compare StudyAugust 21, 2025 | msn.comCatheter Precision, Inc. Enrolls First Patients in LockeT Compare Study Evaluating Safety of Suture Retention DeviceAugust 21, 2025 | quiverquant.comQCatheter Precision Announces the Start of Enrollment for the LockeT Compare StudyAugust 21, 2025 | globenewswire.comWhy Did Catheter Precision Stock Soar 49% Today?August 19, 2025 | msn.comSee More Headlines VTAK Stock Analysis - Frequently Asked Questions How have VTAK shares performed this year? Catheter Precision's stock was trading at $8.5329 at the beginning of the year. Since then, VTAK shares have decreased by 69.8% and is now trading at $2.5760. When did Catheter Precision's stock split? Catheter Precision shares reverse split on Monday, August 18th 2025.The 1-19 reverse split was announced on Friday, August 15th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Catheter Precision? Shares of VTAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Catheter Precision own? Based on aggregate information from My MarketBeat watchlists, some other companies that Catheter Precision investors own include ARMOUR Residential REIT (ARR), Jiuzi (JZXN), Windtree Therapeutics (WINT), AMC Entertainment (AMC), Sphere 3D (ANY), BioCardia (BCDA) and Chemomab Therapeutics (CMMB). Company Calendar Today8/29/2025Next Earnings (Estimated)11/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNYSEAMERICAN:VTAK CIK1716621 Webwww.catheterprecision.com Phone973-691-2000FaxN/AEmployees14Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.64 million Net Margins-3,150.33% Pretax Margin-2,964.00% Return on Equity-193.63% Return on Assets-72.09% Debt Debt-to-Equity Ratio0.19 Current Ratio0.44 Quick Ratio0.43 Sales & Book Value Annual Sales$420 thousand Price / Sales7.54 Cash FlowN/A Price / Cash FlowN/A Book Value$5.34 per share Price / Book0.48Miscellaneous Outstanding Shares1,230,000Free Float1,191,000Market Cap$3.17 million OptionableN/A Beta-0.65 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NYSEAMERICAN:VTAK) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catheter Precision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catheter Precision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.